Agneta K. Nordberg

Agneta K. Nordberg

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 198 publications

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA

Published: July 13, 2026

Author Correction: Curing the brain: in search for new astrocyte-specific therapies.

Author Correction: Curing the brain: in search for new astrocyte-specific therapies.

Journal: Experimental & molecular medicine

Published: May 11, 2026

Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies.

Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies.

Journal: Journal of internal medicine

Published: April 16, 2026

[18F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognition.

[18F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognition.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 16, 2026

Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond.

Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond.

Journal: Current opinion in neurology

Published: February 23, 2026

Curing the brain: in search for new astrocyte-specific therapies.

Curing the brain: in search for new astrocyte-specific therapies.

Journal: Experimental & molecular medicine

Published: October 01, 2025

Find-DLB: a naturalistic cohort of patients presenting with clinical features of dementia with Lewy bodies to a specialized cognitive clinic.

Find-DLB: a naturalistic cohort of patients presenting with clinical features of dementia with Lewy bodies to a specialized cognitive clinic.

Journal: European geriatric medicine

Published: August 05, 2025

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss.

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss.

Journal: Alzheimer's research & therapy

Published: July 30, 2025

Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer's disease mutations.

Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer's disease mutations.

Journal: Translational psychiatry

Published: May 24, 2025

Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients.

Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients.

Journal: Journal of neurochemistry

Published: April 29, 2025

The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review.

The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review.

Journal: AJR. American journal of roentgenology

Published: April 16, 2025

Phenotypic variability in early-onset dementia segregating with a novel APP (p.I718M) variant.

Phenotypic variability in early-onset dementia segregating with a novel APP (p.I718M) variant.

Journal: Alzheimer's research & therapy

Published: March 27, 2025

Showing 1-12 of 198

Last Updated: 09/26/2026